Swiss drugmaker Vifor Pharma is aiming to complete more acquisitions or licensing deals this year, Chief Executive Stefan Schulze told Reuters. ZURICH, March 3 (Reuters) - Swiss drugmaker Vifor ...

Following the IPO, Galenica Group becomes Vifor Pharma Group and will be listed on the Swiss Stock Exchange under its new ticker, VIFN. The company has thus taken the final steps toward separating ...

BRUSSELS, April 19 (Reuters) - Vifor Pharma has offered to launch a marketing campaign to address any damage caused by its criticisms of a rival to its key drug, EU regulators said on Friday ...

ZURICH/SYDNEY, Dec 13 (Reuters) - Vifor Pharma's shares (VIFN.S), opens new tab surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL (CSL.AX), opens new ...